Aveanna Healthcare’s acquisition of Maxim Healthcare Services’ home health division is off, thanks to a Federal Trade Commission investigation of the deal that was announced nearly a year ago. The FTC has “investigated the proposed transaction for several months, including its potential effects in multiple localities across the country on markets both for nursing services and for private duty nursing care,” FTC Chair Joseph Simons says in a release. “As a result of that investigation, staff had concerns about the transaction’s potential anticompetitive effects. Now that the deal has been abandoned, patients and private duty nurses will continue to benefit from competition between Aveanna and Maxim.” When it announced the deal, estimated at $1.25 billion according to press reports, Aveanna noted that although it specializes in pediatric home care, “as a result of overwhelming demand for the quality of care we consistently give, Aveanna has also been providing more and more adult home care services” (see Eli’s HCW, Vol. XXVIII, No. 10).